Systematic review: Persistence and severity in gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 28, Issue 7, 2008, Pages 841-853

  Armstrong, D ^a,b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SUCRALFATE;

BARRETT ESOPHAGUS; CLINICAL TRIAL; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENDOSCOPY; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; PREVALENCE;

EID: 50849084105     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03804.x     Document Type: Review

References (51)

1. Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) - a global evidence-based consensus. Am J Gastroenterol 2006 101: 1900 20.
2. Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population - the Kalixanda study. Aliment Pharmacol Ther 2006 23: 1725 33.
3. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005 54: 710 7.
4. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005 40: 275 85.
5. Zagari RM, Fuccio L, Wallander M-A, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: Loiano-Monghidoro study. Gut 2008 doi :.
6. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003 17: 1481 91.
7. Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Dent J. Comparison of gastroesophageal reflux disease and heartburn diagnoses in UK primary care. Curr Med Res Opin 2006 22: 1661 8.
8. Wong WM, Lim P, Wong BC. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey. J Gastroenterol Hepatol 2004 19 (S3 S54 60.
9. Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005 4: CD003245.
10. Labenz J, Nocon M, Lind T, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol 2006 101: 2457 62.
11. Nocon M, Labenz J, Jaspersen D, et al. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care - results from the ProGERD study. Aliment Pharmacol Ther 2007 25: 715 22.
12. Pace F, Porro GB. Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Am J Gastroenterol 2004 99: 946 9.
13. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997 92: 37 41.
14. Sontag SJ, Sonnenberg A, Schnell TG, Leya J, Metz A. The long-term natural history of gastroesophageal reflux disease. J Clin Gastroenterol 2006 40: 398 404.
15. Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux esophagitis. Gullet 1993 3 (Suppl 3 10.
16. Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol 2002 17: 949 54.
17. El-Serag HB, Gilger M, Carter J, Genta RM, Rabeneck L. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol 2004 99: 806 12.
18. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995 109: 671 80.
19. Agreus L, Svardsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001 96: 2905 14.
20. Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol 2005 20: 995 1001.
21. Wong WM, Lai KC, Lam KF, et al. Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up study. Aliment Pharmacol Ther 2004 20: 803 12.
22. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988 95: 903 12.
23. Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S, Graffner H, Dent J. Natural history of gastroesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004 20: 751 60.
24. Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001 18: 1367 72.
25. Jones R, Liker H, Ducrotte P, Ballard K. Reasons why individuals with symptoms of gastroesophageal reflux disease seek medical attention. Gut 2005 54 (Suppl. VII A63.
26. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR III., Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004 19: 95 105.
27. Locke GR III., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112: 1448 56.
28. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003 98: 1487 93.
29. Jones R, Armstrong D, Malfertheiner P, Ducrotte P. Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study. Curr Med Res Opin 2006 22: 657 62.
30. Jones R, Horbach S, Sander P, Ryden-Bergsten T. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease. Pharmacoeconomics 2003 21: 1091 102.
31. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997 92: 1293 7.
32. Boeckxstaens GE. Review article: the pathophysiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007 26: 149 60.
33. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol 2006 101: 2619 28.
34. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006 130: 639 49.
35. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005 100: 1243 50.
36. Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006 23: 169 74.
37. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006 101: 18 28.
38. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340: 825 31.
39. Becher A, El-Serag HB. Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review. Scand J Gastroenterol 2008 43: 645 53.
40. Talley NJ, Locke GR III., McNally M, Schleck CD, Zinsmeister AR, Melton LJ III. Impact of gastroesophageal reflux on survival in the community. Am J Gastroenterol 2008 103: 12 9.
41. Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004 180: 387 91.
42. El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004 99: 1877 83.
43. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007 5: 17 26.
44. Goh K. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol 2004 19 (S3 S22 5.
45. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992 136: 165 77.
46. Ruth M, Finizia C, Lundell L. Occurrence and future history of oesophageal symptoms in an urban Swedish population: results of a questionnaire-based, ten-year follow-up study. Scand J Gastroenterol 2005 40: 629 35.
47. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003 17: 1515 20.
48. Conio M, Filiberti R, Blanchi S, et al. Risk factors for Barrett's esophagus: a case-control study. Int J Cancer 2002 97: 225 9.
49. Chak A, Faulx A, Eng C, et al. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer 2006 107: 2160 6.
50. Lundell L, Miettinen P, Myrvold HE, et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001 192: 172 81.
51. Vallot T, Bruley des Varannes S, Grimaud JC, et al. Epidemiology of gastro-esophageal-reflux in general practice. Predictive factors for health care utilization in the course of a year. Gastroenterol Clin Biol 1999 23: 1139 44.